First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma—A Retrospective Study

Salivary duct carcinoma

(2018) Emmanuel D’heygere et al.   Current Opinion in Otolaryngology & Head and Neck Surgery

Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands

(2017) Eline Boon et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Characterization, treatment and outcomes of salivary ductal carcinoma using the National Cancer Database

(2017) Virginia Osborn et al.   ORAL ONCOLOGY

Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers

(2015) Laura D. Locati et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Abiraterone in Metastatic Salivary Duct Carcinoma

(2015) Damien Urban et al.   Journal of the National Comprehensive Cancer Network

Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial

(2013) E Hitre et al.   BRITISH JOURNAL OF CANCER

Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options

(2011) Heidy C.J. Jaspers et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer

(2009) Scott A. Laurie et al.   CANCER

Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)

(2009) Laura D. Locati et al.   ORAL ONCOLOGY